Inventor · disambiguated record
Lewis T. Williams
Also filed as: BOSCH ELIZABETH · WILLIAMS LEWIS · WILLIAMS LEWIS T · WILLIAMS LEWIS THOMAS
59 granted patents·41 pending applications·1,282 citations·filing 1990–2023
99Inventor score
Files withUNIV CALIFORNIA31FIVE PRIME THERAPEUTICS INC14CHIRON CORP13WILLIAMS LEWIS T5NOVARTIS VACCINES & DIAGNOSTIC3
Top patents by PatentIndex Score
100 records- 0195US7982014B2FGFR3-IIIc fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2010·Granted Jul 19, 2011·24 cites·12 claims
- 0295US7776523B2Endogenous retroviruses up-regulated in prostate cancerNOVARTIS VACCINES & DIAGNOSTIC·Filed 2001·Granted Aug 17, 2010·79 cites·7 claims
- 0395US6703221B1Notch receptor ligands and uses thereofCHIRON CORP·Filed 2000·Granted Mar 9, 2004·54 cites·9 claims
- 0494US8580936B2Polynucleotides encoding FGFR1-IIIc ECD fusion proteinsWILLIAMS LEWIS T·Filed 2011·Granted Nov 12, 2013·40 cites·25 claims
- 0594US5707632AReceptors for fibroblast growth factorsUNIV CA·Filed 1995·Granted Jan 13, 1998·115 cites·14 claims
- 0693US7279554B2Notch receptor ligands and uses thereofCHIRON CORP·Filed 2003·Granted Oct 9, 2007·33 cites·8 claims
- 0793US6903078B1Combination PDGF, KGF, IGF, and IGFBP for wound healingCHIRON CORP·Filed 2000·Granted Jun 7, 2005·49 cites·2 claims
- 0892US12037604B2Modified B cells and methods of use thereofWALKING FISH THERAPEUTICS·Filed 2023·Granted Jul 16, 2024·4 cites·17 claims
- 0992US11913023B2Modified B cells and methods of use thereofWALKING FISH THERAPEUTICS·Filed 2021·Granted Feb 27, 2024·4 cites·32 claims
- 1089US7776564B2Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of useFIVE PRIME THERAPEUTICS INC·Filed 2005·Granted Aug 17, 2010·15 cites·13 claims
- 1186US8168588B2Compositions comprising FGF-9 and betacellulin and methods for treating cardiac conditionsWILLIAMS LEWIS T·Filed 2006·Granted May 1, 2012·8 cites·18 claims
- 1285US6384191B1Receptors for fibroblast growth factorsUNIV CALIFORNIA·Filed 1990·Granted May 7, 2002·50 cites·8 claims
- 1384US6350593B1Receptors for fibroblast growth factorsUNIV CALIFORNIA·Filed 1995·Granted Feb 26, 2002·54 cites·26 claims
- 1484US5948664API 3-kinase polypeptidesUNIV CALIFORNIA·Filed 1996·Granted Sep 7, 1999·62 cites·16 claims
- 1583US6355440B1Assays using receptors for fibroblast growth factorsUNIV CALIFORNIA·Filed 1995·Granted Mar 12, 2002·48 cites·13 claims
- 1683US6280964B1Binding sites for phosphotyrosine binding domainsUNIV CALIFORNIA·Filed 1995·Granted Aug 28, 2001·42 cites·19 claims
- 1782US7795404B1Human soluble notch receptor ligandsFIVE PRIME THERAPEUTICS INC·Filed 2007·Granted Sep 14, 2010·8 cites·14 claims
- 1882US6974867B2Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizersCHIRON CORP·Filed 2001·Granted Dec 13, 2005·10 cites·4 claims
- 1982US6291220B1Polynucleotides encoding phosphatidylinositol 3-kinasesUNIV CALIFORNIA·Filed 1998·Granted Sep 18, 2001·58 cites·9 claims
- 2080US8324165B2Compositions for treating arthritis comprising HG1023575 polypeptidePENTA KALYANI·Filed 2009·Granted Dec 4, 2012·4 cites·3 claims
- 2179US6964868B1Human genes and gene expression products IINUVELO INC·Filed 1999·Granted Nov 15, 2005·35 cites·9 claims
- 2278US5916763APromoter for VEGF receptorUNIV CALIFORNIA·Filed 1995·Granted Jun 29, 1999·48 cites·20 claims
- 2378US5872218AHuman platelet-derived growth factor receptor extracellular domain antibodiesCOR THERAPEUTICS INC·Filed 1995·Granted Feb 16, 1999·39 cites·8 claims
- 2477US6043211AMethod for inhibiting the activity of a platelet-derived growth factor receptor binding proteinUNIV CALIFORNIA·Filed 1995·Granted Mar 28, 2000·31 cites·12 claims
- 2577US5750653AProtein, FAF1, which potentiates Fas-mediated apoptosis and uses thereofUNIV CALIFORNIA·Filed 1995·Granted May 12, 1998·25 cites·11 claims
- 2676US6110737AHuman platelet-derived growth factor receptor, type AUNIV CALIFORNIA·Filed 1994·Granted Aug 29, 2000·26 cites·10 claims
- 2775US5686572ADomains of extracellular region of human platelet derived growth factor receptor polypeptidesCOR THERAPEUTICS INC·Filed 1993·Granted Nov 11, 1997·35 cites·8 claims
- 2874US7186530B1Protein associated with cell stress responseCHIRON CORP·Filed 2000·Granted Mar 6, 2007·2 cites·15 claims
- 2973US6512102B1Compositions and methods of diagnosis and treatment using casein kinase ICHIRON CORP·Filed 1999·Granted Jan 28, 2003·45 cites·5 claims
- 3073US6001962AModified Fas ligandsUNIV CALIFORNIA·Filed 1996·Granted Dec 14, 1999·31 cites·8 claims
- 3173US2024002793A1Modified b cells and methods of use thereofWALKING FISH THERAPEUTICS·Filed 2023·Application pending·0 cites
- 3273US2009286954A1Human cDNA Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their UseFIVE PRIME THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3372US8575312B2Compositions and methods of use for MGD-CSF in disease treatmentBEHRENS DIRK·Filed 2012·Granted Nov 5, 2013·2 cites·11 claims
- 3471US7105305B2Human platelet-derived growth factor receptorsUNIV CALIFORNIA·Filed 2001·Granted Sep 12, 2006·6 cites·6 claims
- 3570US6110695AModulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1UNIV CALIFORNIA·Filed 1997·Granted Aug 29, 2000·28 cites·33 claims
- 3670US2008182974A1Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their useFIVE PRIME THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3766US9192683B2Methods of treating disease with FGFR1 fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2013·Granted Nov 24, 2015·0 cites·21 claims
- 3865US9173957B2FGFR2 fusion proteins comprising C-terminal deletion mutants of FGFR2-IIICFIVE PRIME THERAPEUTICS INC·Filed 2013·Granted Nov 3, 2015·0 cites·6 claims
- 3964US2017349643A1Compositions and methods of treating disease with fgfr fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4063US8178109B2Compositions and methods of use for MGD-CSF in disease treatmentBEHRENS DIRK·Filed 2009·Granted May 15, 2012·0 cites·12 claims
- 4163US6300111B1Constitutively active phosphatidylinositol 3-kinase and uses thereofUNIV CALIFORNIA·Filed 1999·Granted Oct 9, 2001·13 cites·8 claims
- 4263US5891652AMethods of using domains of extracellular region of human platelet-derived growth factor receptor polypeptidesUNIV CALIFORNIA·Filed 1995·Granted Apr 6, 1999·20 cites·15 claims
- 4363US5744313AAssay employing novel protein domain which binds tyrosine phosphorylated proteinsUNIV CALIFORNIA·Filed 1994·Granted Apr 28, 1998·15 cites·21 claims
- 4463US2006084799A1Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their useWILLIAMS LEWIS T·Filed 2004·Application pending·0 cites
- 4562US2007128710A1Novel protein associated with cell stress responseCHIRON CORP A DELAWARE CORP·Filed 2007·Application pending·0 cites
- 4661US2006035373A1Stem cell librariesZHANG HONGBING·Filed 2004·Application pending·0 cites
- 4759US6001354AGRB2 associating polypeptides and nucleic acids encoding thereforUNIV WASHINGTON·Filed 1995·Granted Dec 14, 1999·12 cites·15 claims
- 4859US2016096876A1Compositions and methods of treating disease with fgfr fusion proteinsFIVE PRIME THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4959US2005250695A1Combination PDGF, KGF, IGF, and IGFBP for wound healingCHIRON CORP·Filed 2005·Application pending·0 cites
- 5058US6958238B2Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereofUNIV CALIFORNIA·Filed 2003·Granted Oct 25, 2005·1 cites·7 claims
Showing the top 50 of 100 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →